HIV-1 Tat-Based Vaccines: From Basic Science to Clinical Trials-Reference-Cited by-同舟云学术

HIV-1 Tat-Based Vaccines: From Basic Science to Clinical Trials

Published:2002-09 Issue:9 Volume:21 Page:599-610
ISSN:1044-5498
Container-title:DNA and Cell Biology
language:en
Short-container-title:DNA and Cell Biology

Author:

Fanales-Belasio Emanuele¹,Cafaro Aurelio¹,Cara Andrea¹,Negri Donatella R.M.¹,Fiorelli Valeria¹,Butto Stefano¹,Moretti Sonia¹,Maggiorella Maria Teresa¹,Baroncelli Silvia¹,Michelini Zuleika¹,Tripiciano Antonella¹,Sernicola Leonardo¹,Scoglio Arianna¹,Borsetti Alessandra¹,Ridolfi Barbara¹,Bona Roberta¹,ten Haaft Peter²,Macchia Iole¹,Leone Pasqualina¹,Pavone-Cossut Maria Rosaria¹,Nappi Filomena¹,Vardas Eftyhia³,Magnani Mauro⁴,Laguardia Elena⁴,Caputo Antonella⁵,Titti Fausto¹,Ensoli Barbara¹

Affiliation:

1. Laboratory of Virology, Istituto Superiore di Sanità, Rome, Italy

2. Department of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands

3. Chris Hani Baragwanath Hospital and University of the Witwatersrand, South Africa

4. Institute of Biological Chemistry "Giorgio Fornaini," University of Urbino, 61029 Urbino, Italy

5. Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Genetics,Molecular Biology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/104454902760330138

Reference50 articles.

1. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals

2. Tat-Vaccinated Macaques Do Not Control Simian Immunodeficiency Virus SIVmac239 Replication

3. Quantifying the uncertainty in forecasts of anthropogenic climate change

4. Trans -Activator Gene of Human T-Lymphotropic Virus Type III (HTLV-III)

5. Pathogenicity of Live, Attenuated SIV After Mucosal Infection of Neonatal Macaques

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biocompatibility of engineered nanoparticles for drug delivery;Journal of Controlled Release;2013-03

2. Enhancing immunogenicity and cross-reactivity of HIV-1 antigens byin vivotargeting to dendritic cells;Nanomedicine;2012-10

3. Induction of anti-Tat neutralizing antibodies by the CyaA vector targeting dendritic cells: Influence of the insertion site and of the delivery of multicopies of the dominant Tat B-cell epitope;Vaccine;2010-10

4. Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking;Molecular and Cellular Biochemistry;2010-08-20

5. Contribution of Nonneutralizing Vaccine-Elicited Antibody Activities to Improved Protective Efficacy in Rhesus Macaques Immunized with Tat/Env Compared with Multigenic Vaccines;The Journal of Immunology;2009-03-05